MENU
PYXS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Pyxis Oncology (PYXS) Ownership - Who owns Pyxis Oncology?
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients... Show more
Profile
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 221-9059
Employees
50
Web
https://www.pyxisoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
56.36M
P/E Ratio
N/A
Total Cash
126.93M
Projected Growth
N/A
Total Debt
20.2M
Revenue
16.15M
Risk (Beta)
1.03
Dividend Yield
N/A
Total Cash/Share
2.06
Total Debt/Equity
N/A
Revenue/Share
0.28 USD as % of share price
Fundamentals
PYXS
Capitalization
56.4M
P/E Ratio
N/A
Risk (Beta)
1.03
Dividend Yield
N/A
Total Cash
127M
Total Cash/Share
2.06
Total Debt
20.2M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.28%
Revenue
16.1M
ROE
N/A
Book Value
121M
P/B Ratio
0.47
Cash Flow
N/A
Earnings
-1.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
60K
Current Ratio
7.49
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-65.51M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-46.74
Shares Held By Institutions
63.5M
Shares Outstanding - Current
61.6M
Total Liabilities
36.4M
Total Volume MTD
N/A
Value
1
Gain YTD
-41.346
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 221-9059
Employees
50
Web
https://www.pyxisoncology.com